Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Therapeutics symbols : Vvos save search
Vivos Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Operational Update
Published: 2024-03-28 (Crawled : 20:00) - globenewswire.com
VVOS | $2.66 300
|
Health Technology
| Email alert
Add to watchlist
NVST | $19.75 0.82% 0.0% 0
|
Health Technology
| Email alert
Add to watchlist
year update therapeutics financial results
Vivos Therapeutics Announces Exercise of Warrants for Approximately $4.0 Million Aggregate Gross Proceeds
Published: 2024-02-15 (Crawled : 13:00) - globenewswire.com
VVOS | $2.66 300
|
Health Technology
|
| O: -0.79%
H: 10.01%
C: 6.99%
million therapeutics
Vivos Therapeutics Highlights Significant Favorable Market Developments Creating Exciting New Growth Opportunities
Published: 2024-02-06 (Crawled : 12:30) - globenewswire.com
VVOS | $2.66 300
|
Health Technology
|
| O: 11.65%
H: 0.47%
C: -14.8%
favorable therapeutics growth market
Vivos Therapeutics Sees Positive Preliminary Metrics Following Unprecedented FDA 510(k) Clearance of the Company’s Proprietary Oral Medical Devices to Treat Severe OSA
Published: 2024-01-08 (Crawled : 12:30) - globenewswire.com
VVOS | $2.66 300
|
Health Technology
|
| O: 4.93%
H: 1.82%
C: -3.47%
fda positive treat clearance medical therapeutics
Vivos Therapeutics Presents Groundbreaking Event: “Empowering Women to Champion Airway”
Published: 2023-12-11 (Crawled : 12:30) - globenewswire.com
VVOS | $2.66 300
|
Health Technology
|
| O: 0.52%
H: 3.31%
C: -14.88%
women therapeutics
Vivos Therapeutics Receives First Ever FDA 510(k) Clearance for Oral Device Treatment of Severe Obstructive Sleep Apnea
Published: 2023-11-29 (Crawled : 12:30) - globenewswire.com
VVOS | $2.66 300
|
Health Technology
|
| O: 171.75%
H: 308.97%
C: 243.67%
fda device treatment clearance therapeutics
Vivos Therapeutics Reports Third Quarter 2023 Financial Results and Provides Operational Update
Published: 2023-11-14 (Crawled : 21:00) - globenewswire.com
VVOS | $2.66 300
|
Health Technology
|
| O: 5.9%
H: 8.86%
C: -2.53%
NVST | $19.75 0.82% 0.0% 0
|
Health Technology
|
| O: -0.76%
H: 5.28%
C: 4.78%
update therapeutics financial results
Vivos Therapeutics Schedules Release of Third Quarter 2023 Financial Results and Conference Call
Published: 2023-11-09 (Crawled : 21:00) - globenewswire.com
VVOS | $2.66 300
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -5.84%
conference therapeutics financial results
Vivos Therapeutics Closes $4 Million Private Placement
Published: 2023-11-02 (Crawled : 21:00) - globenewswire.com
VVOS | $2.66 300
|
Health Technology
|
| O: -3.87%
H: 10.06%
C: -1.72%
therapeutics
Vivos Therapeutics Announces Pricing of $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules
Published: 2023-10-31 (Crawled : 12:00) - globenewswire.com
VVOS | $2.66 300
|
Health Technology
|
| O: -6.27%
H: 0.0%
C: -10.58%
nasdaq therapeutics
Vivos Therapeutics Announces Reverse Stock Split1-for-25 reverse stock split to become effective as of the opening of trading tomorrow, October 27, 2023
Published: 2023-10-26 (Crawled : 14:00) - biospace.com/
VVOS | $2.66 300
|
Health Technology
|
| O: 1.29%
H: 1.77%
C: -8.09%
therapeutics
Vivos Therapeutics Announces Reverse Stock Split
Published: 2023-10-26 (Crawled : 12:00) - globenewswire.com
VVOS | $2.66 300
|
Health Technology
|
| O: 1.29%
H: 1.77%
C: -8.09%
therapeutics
Vivos Therapeutics Signs Nationwide Distribution Agreement with Lincare
Published: 2023-10-24 (Crawled : 12:00) - globenewswire.com
VVOS | $2.66 300
|
Health Technology
|
| O: 11.51%
H: 0.97%
C: -15.48%
distribution therapeutics agreement
Vivos Therapeutics to Begin Clinical Trial at Stanford Medicine
Published: 2023-10-11 (Crawled : 12:00) - globenewswire.com
VVOS | $2.66 300
|
Health Technology
|
| O: -5.09%
H: 16.09%
C: 9.37%
trial therapeutics
Vivos Therapeutics Announces Strategic Collaboration in the Middle East-North Africa Region to Support International Expansion
Published: 2023-10-05 (Crawled : 12:00) - globenewswire.com
VVOS | $2.66 300
|
Health Technology
|
| O: 15.63%
H: 1.96%
C: -7.55%
international expansion collaboration therapeutics africa
Vivos Therapeutics Executes Strategic Agreements with Ormco and On Demand Orthodontist To Provide Spark™ Clear Aligners to Its National Network of Providers
Published: 2023-10-04 (Crawled : 12:00) - globenewswire.com
VVOS | $2.66 300
|
Health Technology
|
| O: 45.95%
H: 66.59%
C: 12.78%
NVST | $19.75 0.82% 0.0% 0
|
Health Technology
|
| O: 0.26%
H: 0.52%
C: -0.66%
network therapeutics
Vivos Therapeutics Reports Second Quarter 2023 Financial Results and Provides Operational Update
Published: 2023-08-16 (Crawled : 20:00) - globenewswire.com
VVOS | $2.66 300
|
Health Technology
|
| O: -1.64%
H: 3.68%
C: -1.27%
update therapeutics financial results
Vivos Therapeutics Reschedules Second Quarter 2023 Financial Results Conference Call
Published: 2023-08-16 (Crawled : 12:00) - globenewswire.com
VVOS | $2.66 300
|
Health Technology
|
| O: 5.53%
H: 0.0%
C: 0.0%
conference therapeutics results
Vivos Therapeutics to Reschedule Second Quarter 2023 Financial Results Conference Call
Published: 2023-08-14 (Crawled : 21:00) - globenewswire.com
VVOS | $2.66 300
|
Health Technology
|
| O: -9.3%
H: 0.0%
C: 0.0%
conference therapeutics financial results
Vivos Therapeutics Schedules Release of Second Quarter 2023 Financial Results and Conference Call
Published: 2023-08-11 (Crawled : 00:00) - globenewswire.com
VVOS | $2.66 300
|
Health Technology
|
| O: 6.46%
H: 13.91%
C: 12.81%
conference therapeutics financial results
Gainers vs Losers
| 63% | 37% |
Top 10 Gainers
AGBA | News | $1.4 250.0% 35M
|
Finance
RWOD | $12.0 50.06% 3.9M
|
n/a
INDO | $4.9 20.1% 2.2M
|
Energy Minerals
NURO | $4.32 18.36% 66K
|
Health Technology
HUBC | $1.52 17.83% 4.7M
|
n/a
CARV 4 | $1.77 11.32% 8.5K
|
Finance
BROG | $1.23 10.81% 320K
|
Finance
PARA | $12.03 9.66% 5.8M
|
Information
ADAP | $0.98 9.08% 240K
|
Health Technology
POAI A | $1.25 8.69% 16K
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.